<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03984240</url>
  </required_header>
  <id_info>
    <org_study_id>81701038</org_study_id>
    <nct_id>NCT03984240</nct_id>
  </id_info>
  <brief_title>The Effects of Mild Sedation on Motor Function Networks in Patients With Brian Gliomas</brief_title>
  <official_title>The Effects of Mild Sedation on Compensatory Upper Limb Motor Function Networks Based on Multimodal Magnetic Resonance Imaging in With Gliomas in Brain Eloquent Areas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown through functional MRI (Magnetic Resonance Imaging) that patients with&#xD;
      gliomas in eloquent areas have compensated neurological function by virtue of brain&#xD;
      post-injury reorganization. Our previous clinical research found that mild sedation could&#xD;
      induce and/or exacerbate neurological deficits, especially in limb motor and ataxia function,&#xD;
      in these patients presumably by impairing functional compensation,. Nevertheless it is still&#xD;
      very unclear how mild sedation affects sensorimotor networks in brains where reorganization&#xD;
      may be present. Since eloquent area glioma patients are frequently subjected to sedation,&#xD;
      anesthetics, and neurological examinations perioperatively, it is important to investigate&#xD;
      how mild sedation interacts with motor network reorganization and functional compensation.&#xD;
      Our research in patients with eloquent area gliomas will utilize neurological evaluations and&#xD;
      multimodal MRI to explore the changes in brain upper limb' motor network reorganization after&#xD;
      mild sedation by different sedatives-anesthetics. The neurological evaluations include&#xD;
      sensorimotor function scale and testing tool. Multimodal MRI consists of 3-dimentional&#xD;
      structure, blood oxygen-level dependent for cortical activation and diffusion tensor imaging&#xD;
      for subcortical conduction. The data from the clinical testing and functional MRI will be&#xD;
      processed and analyzed along with other relevant clinical information. This research will&#xD;
      answer the question of how mild sedation affects upper limb motor function networks in brains&#xD;
      with eloquent area gliomas. This new information will help optimize perioperative anesthetic&#xD;
      and sedative choice for patients with eloquent area gliomas.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain network connectivity</measure>
    <time_frame>2 hours following sedation</time_frame>
    <description>will use fMRI and DTI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>upper limb's motor function</measure>
    <time_frame>2 hours following sedation</time_frame>
    <description>will use 9-hole peg test and motor/sensory function evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pathological diagnose of glioma</measure>
    <time_frame>2 weeks after surgery completion</time_frame>
    <description>the detailed type of glioma and WHO glioma grade</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brain Glioma</condition>
  <arm_group>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The brain eloquent area glioma will be diagnosed by MRI scan.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers without intracranial diseases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Participant will be sedated by midazolam.</description>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Participant will be sedated by dexmedetomidine.</description>
    <arm_group_label>Brain eloquent area glioma group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 25 to 60 years old;&#xD;
&#xD;
          -  Diagnosed as intracranial eloquent glioma by MRI, or healthy volunteer without any&#xD;
             intracranial disease;&#xD;
&#xD;
          -  Without history of chronic diseases;&#xD;
&#xD;
          -  Without internal and/external metal object;&#xD;
&#xD;
          -  Education background is beyond high school;&#xD;
&#xD;
          -  Right handedness&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to cooperate the neurologic function evaluation;&#xD;
&#xD;
          -  Neuropsychiatric disorders and/or taking antipsychotic medications;&#xD;
&#xD;
          -  Drug and/or alcohol abuse;&#xD;
&#xD;
          -  Receiving longterm sedatives and/or analgesics;&#xD;
&#xD;
          -  Pregnant and/or lactation period patients;&#xD;
&#xD;
          -  Present severe cardiovascular diseases;&#xD;
&#xD;
          -  Having claustrophobia;&#xD;
&#xD;
          -  Body mass index equal or more than 35 kg/m2;&#xD;
&#xD;
          -  Anticipated difficult airway;&#xD;
&#xD;
          -  History of severe obstructive sleep apnea;&#xD;
&#xD;
          -  History of reflux&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nan LIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nan LIN, MD, PhD</last_name>
    <phone>8610-13810108927</phone>
    <email>linnan127@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100055</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nan Lin, MD</last_name>
      <phone>8610-13810108927</phone>
      <email>linnan127@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>中国</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 8, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>December 20, 2020</last_update_submitted>
  <last_update_submitted_qc>December 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Nan Lin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>midazolam, dexmedetomidine, motor function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

